Association between NUDT17 polymorphisms and breast cancer risk

Expert Rev Mol Diagn. 2024 May;24(5):459-466. doi: 10.1080/14737159.2024.2353700. Epub 2024 May 17.

Abstract

Background: Breast cancer (BC) is the leading cause of cancer death among women worldwide. The nudix hydrolase 17 (NUDT17) may play notable roles in cancer growth and metastasis. In this study, we explored the importance of NUDT17 gene polymorphism in patients with BC.

Methods: In our study, 563 BC patients and 552 healthy controls participated. We used logistic regression analysis to calculate odds ratios (OR) and 95% confidence intervals (CI), and multifactor dimension reduction (MDR) analysis of SNP-SNP interactions. Finally, UALCAN and THPA databases were used for bioinformatics analysis.

Results: The rs9286836 G allele was associated with a decreased the BC risk (p = 0.022), and the carriers of rs2004659 G allele had a 32% decreased risk of BC than individuals with allele A (p = 0.004). In the four genetic models, rs9286836 and rs2004659 reduced the risk of BC. Additionally, we found that the NUDT17 SNPs were associated with BC risk under age, tumor size, and clinical stage stratification. The MDR analysis showed that the five-locus interaction model was the best in the multi-locus model.

Conclusion: Our study found that NUDT17 single nucleotide polymorphisms are associated with BC susceptibility in Chinese Han population.

Keywords: Breast cancer; Chinese Han population; NUDT17; correlation analysis; single nucleotide polymorphism.

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Breast Neoplasms* / genetics
  • Case-Control Studies
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Middle Aged
  • Odds Ratio
  • Polymorphism, Single Nucleotide*
  • Pyrophosphatases* / genetics
  • Risk Factors